The conflict between treatment optimization and registration of radiopharmaceuticals with fixed activity posology in oncological nuclear medicine therapy
Crossref DOI link: https://doi.org/10.1007/s00259-017-3707-3
Published Online: 2017-05-24
Published Print: 2017-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chiesa, C. http://orcid.org/0000-0003-0634-013X
Sjogreen Gleisner, K.
Flux, G.
Gear, J.
Walrand, S.
Bacher, K.
Eberlein, U.
Visser, E. P.
Chouin, N.
Ljungberg, M.
Bardiès, M.
Lassmann, M.
Strigari, L.
Konijnenberg, M. W.
License valid from 2017-05-24